Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 4 | 2020 | 547 | 0.890 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2022 | 148 | 0.890 |
Why?
|
| Chromosome Mapping | 1 | 2020 | 193 | 0.710 |
Why?
|
| Genomics | 1 | 2020 | 85 | 0.700 |
Why?
|
| Genome, Human | 1 | 2020 | 132 | 0.700 |
Why?
|
| DNA | 1 | 2020 | 226 | 0.660 |
Why?
|
| Fatty Acid Desaturases | 5 | 2018 | 48 | 0.610 |
Why?
|
| HLA-C Antigens | 1 | 2017 | 3 | 0.610 |
Why?
|
| Heart Block | 1 | 2017 | 9 | 0.600 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2020 | 1062 | 0.560 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 291 | 0.450 |
Why?
|
| African Continental Ancestry Group | 3 | 2020 | 363 | 0.390 |
Why?
|
| DNA Methylation | 3 | 2018 | 141 | 0.390 |
Why?
|
| STAT4 Transcription Factor | 3 | 2020 | 15 | 0.380 |
Why?
|
| European Continental Ancestry Group | 7 | 2020 | 1166 | 0.350 |
Why?
|
| Quantitative Trait Loci | 2 | 2020 | 140 | 0.330 |
Why?
|
| Polymorphism, Genetic | 2 | 2018 | 184 | 0.290 |
Why?
|
| American Native Continental Ancestry Group | 2 | 2017 | 13 | 0.280 |
Why?
|
| Multigene Family | 3 | 2017 | 51 | 0.280 |
Why?
|
| Genotype | 4 | 2018 | 733 | 0.230 |
Why?
|
| Linkage Disequilibrium | 4 | 2017 | 185 | 0.230 |
Why?
|
| Alleles | 3 | 2018 | 248 | 0.210 |
Why?
|
| Case-Control Studies | 4 | 2017 | 898 | 0.210 |
Why?
|
| Hemophilia A | 1 | 2022 | 25 | 0.210 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 147 | 0.210 |
Why?
|
| Humans | 16 | 2022 | 32005 | 0.210 |
Why?
|
| Sjogren's Syndrome | 1 | 2022 | 36 | 0.200 |
Why?
|
| Logistic Models | 3 | 2018 | 781 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2017 | 835 | 0.190 |
Why?
|
| Mothers | 2 | 2022 | 88 | 0.190 |
Why?
|
| src-Family Kinases | 1 | 2020 | 16 | 0.190 |
Why?
|
| Databases, Genetic | 1 | 2020 | 37 | 0.190 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2022 | 182 | 0.180 |
Why?
|
| Bayes Theorem | 1 | 2020 | 80 | 0.180 |
Why?
|
| Base Sequence | 1 | 2020 | 252 | 0.180 |
Why?
|
| Siblings | 2 | 2017 | 25 | 0.170 |
Why?
|
| Proteins | 1 | 2020 | 144 | 0.170 |
Why?
|
| Infant, Newborn | 2 | 2022 | 671 | 0.170 |
Why?
|
| Odds Ratio | 2 | 2017 | 472 | 0.170 |
Why?
|
| STAT1 Transcription Factor | 1 | 2018 | 12 | 0.160 |
Why?
|
| Rheumatoid Factor | 1 | 2018 | 4 | 0.160 |
Why?
|
| Saliva | 1 | 2018 | 36 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 40 | 0.150 |
Why?
|
| Leukocytes | 1 | 2018 | 57 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 55 | 0.150 |
Why?
|
| Autoantibodies | 1 | 2018 | 49 | 0.150 |
Why?
|
| Antibodies, Antinuclear | 1 | 2017 | 18 | 0.150 |
Why?
|
| Fathers | 1 | 2017 | 12 | 0.150 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 24 | 0.150 |
Why?
|
| Europe | 1 | 2017 | 82 | 0.150 |
Why?
|
| Genetic Load | 1 | 2017 | 4 | 0.150 |
Why?
|
| Pedigree | 1 | 2017 | 140 | 0.150 |
Why?
|
| Molecular Epidemiology | 1 | 2017 | 20 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 153 | 0.150 |
Why?
|
| HLA Antigens | 1 | 2017 | 40 | 0.140 |
Why?
|
| Hispanic Americans | 2 | 2020 | 940 | 0.140 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2016 | 7 | 0.140 |
Why?
|
| Pulmonary Fibrosis | 1 | 2016 | 10 | 0.140 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 104 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 28 | 0.140 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2016 | 108 | 0.130 |
Why?
|
| Female | 9 | 2022 | 19959 | 0.130 |
Why?
|
| Sex Factors | 1 | 2017 | 663 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2016 | 136 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2016 | 256 | 0.120 |
Why?
|
| United States | 3 | 2017 | 3939 | 0.110 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 34 | 0.110 |
Why?
|
| Male | 7 | 2018 | 19165 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 55 | 0.100 |
Why?
|
| Arachidonic Acid | 1 | 2011 | 35 | 0.100 |
Why?
|
| Animals | 1 | 2017 | 7541 | 0.060 |
Why?
|
| Adult | 4 | 2018 | 9345 | 0.060 |
Why?
|
| Child | 2 | 2022 | 2438 | 0.060 |
Why?
|
| Factor VIII | 1 | 2022 | 25 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1428 | 0.050 |
Why?
|
| Placenta | 1 | 2022 | 74 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2012 | 220 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2022 | 189 | 0.050 |
Why?
|
| Pregnancy | 1 | 2022 | 997 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2018 | 24 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 81 | 0.040 |
Why?
|
| CpG Islands | 1 | 2017 | 45 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 2017 | 15 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2017 | 40 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2017 | 21 | 0.040 |
Why?
|
| Demography | 1 | 2017 | 109 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 137 | 0.040 |
Why?
|
| African Americans | 2 | 2017 | 1425 | 0.040 |
Why?
|
| Age of Onset | 1 | 2017 | 94 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 11817 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2016 | 19 | 0.030 |
Why?
|
| OX40 Ligand | 1 | 2016 | 6 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2016 | 12 | 0.030 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2016 | 4 | 0.030 |
Why?
|
| Argentina | 1 | 2016 | 5 | 0.030 |
Why?
|
| Chile | 1 | 2016 | 7 | 0.030 |
Why?
|
| beta Karyopherins | 1 | 2016 | 6 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2016 | 8 | 0.030 |
Why?
|
| HLA-DQ Antigens | 1 | 2016 | 8 | 0.030 |
Why?
|
| Peru | 1 | 2016 | 21 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2016 | 13 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2016 | 14 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 632 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 68 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 71 | 0.030 |
Why?
|
| Haplotypes | 1 | 2016 | 220 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2016 | 146 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 322 | 0.030 |
Why?
|
| alpha-Linolenic Acid | 1 | 2014 | 11 | 0.030 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2014 | 30 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 495 | 0.030 |
Why?
|
| Africa | 1 | 2012 | 27 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2012 | 35 | 0.030 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2011 | 13 | 0.020 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2011 | 29 | 0.020 |
Why?
|
| Family Health | 1 | 2011 | 76 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 146 | 0.020 |
Why?
|
| Liver | 1 | 2014 | 484 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 2636 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 10301 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 3876 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 3539 | 0.020 |
Why?
|